The Ozempic Personality, Oral vs. Injectable Peptides, Hashimoto's, Puffy Eyes & Weak Nails | Ask Me Anything

In this Ask Me Anything episode, Dr. Will Cole and his team tackle listener questions on periorbital edema with Hashimoto's, what your fingernails are communicating about your metabolic and immune health, and the oral vs. injectable GLP-1 debate. They also address a question that's generating a lot of conversation online: are GLP-1 medications blunting dopamine in ways that affect desire, relationships, and emotional connection — and what can be done about it? As always, the team brings both the clinical nuance and the real-world perspective. For all links mentioned in this episode, visit http://www.drwillcole.com/podcast

Please note that this episode may contain paid endorsements and advertisements for products and services. Individuals on the show may have a direct or indirect financial interest in products or services referred to in this episode.

Sponsors:

• Find out more at apple.com/health. This message was brought to you by Apple and AT&T. Apple Watch is not a medical device and should not be used as a substitute for professional medical advice. 
• Text ABW to 64000 to get 20% off all IQBAR products, plus FREE shipping. Message and data rates may apply.
• Go to fromourplace.com and enter my code WILLCOLE at check out to receive 10% off site wide. Our Place offers a 100 day trial with free shipping and returns.
• Refresh your wardrobe with Quince. Go to Quince.com/willcole for free shipping and 365-day returns. Now available in Canada, too.
• Go to CLEARSTEM.com/WILLCOLE and use code WILLCOLE at checkout and receive a free mini HYDRAGLOW plumping Moisturizer when you spend $75 or more.
• To learn more and get 20% off your order, visit ActiveSkinRepair.com and use code: WILLCOLE . You can also find Active Skin Repair on Amazon and at your local CVS.

Produced by Dear Media.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.